Aims and Scope of Journal of Receptor and Signal Transduction Research
The Journal of Receptors and Signal Transduction is a peer-reviewed scientific journal that publishes laboratory and clinical studies, reviews, and brief communications on biological receptors and associated signal transduction pathways for ligands involved in the regulation of central and peripheral tissues and cells. It is published by Informa. The editors in chief are Alex N. Eberle (University of Basel, Switzerland) and Terrence Kenakin (GlaxoSmithKline, Research Triangle Park, NC, United States). Less
Key Metrics
CiteScore 

3.4
H-Index 

51
Impact Factor 

< 5
SJR 

Q3Biochemistry

SNIP 

0.64
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Receptor and Signal Transduction Research
Journal of Receptor and Signal Transduction Research Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2003 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Receptor and Signal Transduction Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Receptor and Signal Transduction Research
In silico investigation of novel isatin derivatives as potential multi-target anticancer agents targeting VEGFR-2, EGFR, and caspase-6
- 1 Aug 2026
- Journal of Receptors and Signal Transduction
Molecular insights into voltage-gated sodium channels in excitable cells: pathophysiological roles and emerging therapeutic targets
- 30 May 2026
- Journal of Receptors and Signal Transduction
Pharmacophore-based identification and molecular docking of CCR5 inhibitors: insights from dynamic simulations
- 4 May 2026
- Journal of Receptors and Signal Transduction
Identification of receptor-interacting protein kinase 3 inhibitor for atherosclerosis
- 4 May 2026
- Journal of Receptors and Signal Transduction
Computational design, synthesis, and in vitro evaluation of thiadiazole-derived PARP-1 inhibitors
- 4 May 2026
- Journal of Receptors and Signal Transduction
In silico investigation of Panchagavya Ghrita’s anticancer potential against glioblastoma: a network pharmacology and molecular docking study
- 4 May 2026
- Journal of Receptors and Signal Transduction
In silico investigation of novel isatin derivatives as potential multi-target anticancer agents targeting VEGFR-2, EGFR, and caspase-6
- 1 Aug 2026
- Journal of Receptors and Signal Transduction
Molecular insights into voltage-gated sodium channels in excitable cells: pathophysiological roles and emerging therapeutic targets
- 30 May 2026
- Journal of Receptors and Signal Transduction
Pharmacophore-based identification and molecular docking of CCR5 inhibitors: insights from dynamic simulations
- 4 May 2026
- Journal of Receptors and Signal Transduction
Identification of receptor-interacting protein kinase 3 inhibitor for atherosclerosis
- 4 May 2026
- Journal of Receptors and Signal Transduction
Computational design, synthesis, and in vitro evaluation of thiadiazole-derived PARP-1 inhibitors
- 4 May 2026
- Journal of Receptors and Signal Transduction
In silico investigation of Panchagavya Ghrita’s anticancer potential against glioblastoma: a network pharmacology and molecular docking study
- 4 May 2026
- Journal of Receptors and Signal Transduction